Prothena to Report First Quarter 2026 Financial Results on May 7
City A.M. | London's Business Newspaper - News, Opinion, & Anal…
April 30, 2026
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that it will report its first quarter 2026 financial results on Thursday, May 7, 2026, after the close of the U.S. financial markets. Consistent with past practice, the Company will not be [...]
Discussion in the ATmosphere